The Wyss is developing a computation-based approach to streamline the identification & validation of novel target compounds. This type of approach is being applied to the challenge of finding FDA-approved drugs & drug combinations to use against COVID-19. wyss.harvard.edu/technology/usi…
0
2
14
0
0